Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by HUB Investment Partners LLC

HUB Investment Partners LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 64,487 shares of the medical equipment provider’s stock after selling 915 shares during the quarter. Intuitive Surgical makes up 1.4% of HUB Investment Partners LLC’s portfolio, making the stock its 10th largest position. HUB Investment Partners LLC’s holdings in Intuitive Surgical were worth $33,660,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new stake in Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $36,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $492.06 on Thursday. The stock has a fifty day moving average price of $564.39 and a 200-day moving average price of $531.62. The company has a market cap of $175.26 billion, a price-to-earnings ratio of 76.76, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Activity

In related news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Finally, BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.